Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 1995 May;50(5):555–559. doi: 10.1136/thx.50.5.555

Nephrolithiasis as a presenting feature of chronic sarcoidosis.

G Rizzato 1, P Fraioli 1, L Montemurro 1
PMCID: PMC1021229  PMID: 7597671

Abstract

BACKGROUND--Renal calculi have been reported to occur in about 10% of patients with chronic sarcoidosis, but nephrolithiasis as a presentation of this disease has not been studied. METHODS--The charts of 618 patients with histologically proven sarcoidosis, seen in the period October 1978-1992, were reviewed in order to identify nephrolithiasis at presentation. RESULTS--Seventeen patients had renal calculi which preceded other manifestations of sarcoidosis. In six the occurrence of calculi suggested the diagnosis. Another eight patients had a previous history of recurrent colic with calculi. The time intervals between the first calculus and the appearance of other manifestations of sarcoidosis ranged from one to 25 years, but it was over four years in only two cases and all had at least one calculus in the year before the diagnosis was made. In the other three patients appearance of the calculus was distant in time and was probably unrelated to their sarcoidosis. In most cases the sarcoidosis was chronic and needed long term treatment with corticosteroids. Four patients had further calculi during follow up (one month to 16 years) due to an improper withdrawal of treatment decided by the patient in two cases, and to the reduction in the corticosteroid dose in the other two. CONCLUSIONS--Calculi were the presenting feature of sarcoidosis in six (1%) patients, and were the first manifestation of the disease in a total of 14 (2.2%). This frequency is over 20 times the likely incidence of calculi in the general population. Renal calculi may therefore be a rare primary manifestation of sarcoidosis. In such cases the disease is likely to be chronic and to require long term corticosteroid therapy. Sarcoidosis should always be suspected in cases of nephrolithiasis of unknown origin.

Full text

PDF
555

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ALBRIGHT F., CARROLL E. L., DEMPSEY E. F., HENNEMAN P. H. The cause of hypercalcuria in sarcoid and its treatment with cortisone and sodium phytate. J Clin Invest. 1956 Nov;35(11):1229–1242. doi: 10.1172/JCI103378. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Adams J. S., Gacad M. A., Singer F. R., Sharma O. P. Production of 1,25-dihydroxyvitamin D3 by pulmonary alveolar macrophages from patients with sarcoidosis. Ann N Y Acad Sci. 1986;465:587–594. doi: 10.1111/j.1749-6632.1986.tb18535.x. [DOI] [PubMed] [Google Scholar]
  3. Barbour G. L., Coburn J. W., Slatopolsky E., Norman A. W., Horst R. L. Hypercalcemia in an anephric patient with sarcoidosis: evidence for extrarenal generation of 1,25-dihydroxyvitamin D. N Engl J Med. 1981 Aug 20;305(8):440–443. doi: 10.1056/NEJM198108203050807. [DOI] [PubMed] [Google Scholar]
  4. Bell N. H., Stern P. H., Pantzer E., Sinha T. K., DeLuca H. F. Evidence that increased circulating 1 alpha, 25-dihydroxyvitamin D is the probable cause for abnormal calcium metabolism in sarcoidosis. J Clin Invest. 1979 Jul;64(1):218–225. doi: 10.1172/JCI109442. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Borghi L., Ferretti P. P., Elia G. F., Amato F., Melloni E., Trapassi M. R., Novarini A. Epidemiological study of urinary tract stones in a northern Italian city. Br J Urol. 1990 Mar;65(3):231–235. doi: 10.1111/j.1464-410x.1990.tb14716.x. [DOI] [PubMed] [Google Scholar]
  6. Curhan G. C., Rimm E. B., Willett W. C., Stampfer M. J. Regional variation in nephrolithiasis incidence and prevalence among United States men. J Urol. 1994 Apr;151(4):838–841. doi: 10.1016/s0022-5347(17)35101-7. [DOI] [PubMed] [Google Scholar]
  7. Emamian S. A., Nielsen M. B., Pedersen J. F., Ytte L. Sonographic evaluation of renal appearance in 665 adult volunteers. Correlation with age and obesity. Acta Radiol. 1993 Sep;34(5):482–485. [PubMed] [Google Scholar]
  8. HODGKINSON A., PYRAH L. N. The urinary excretion of calcium and inorganic phosphate in 344 patients with calcium stone of renal origin. Br J Surg. 1958 Jul;46(195):10–18. doi: 10.1002/bjs.18004619504. [DOI] [PubMed] [Google Scholar]
  9. Hiatt R. A., Dales L. G., Friedman G. D., Hunkeler E. M. Frequency of urolithiasis in a prepaid medical care program. Am J Epidemiol. 1982 Feb;115(2):255–265. doi: 10.1093/oxfordjournals.aje.a113297. [DOI] [PubMed] [Google Scholar]
  10. James D. G. Lupus pernio. Lupus. 1992 May;1(3):129–131. doi: 10.1177/096120339200100302. [DOI] [PubMed] [Google Scholar]
  11. Johnson C. M., Wilson D. M., O'Fallon W. M., Malek R. S., Kurland L. T. Renal stone epidemiology: a 25-year study in Rochester, Minnesota. Kidney Int. 1979 Nov;16(5):624–631. doi: 10.1038/ki.1979.173. [DOI] [PubMed] [Google Scholar]
  12. LOFGREN S., SNELLMAN B., LINDGREN A. G. Renal complications in sarcoidosis; functional and biopsy studies. Acta Med Scand. 1957 Dec 12;159(4):295–305. [PubMed] [Google Scholar]
  13. LONGCOPE W. T., FREIMAN D. G. A study of sarcoidosis; based on a combined investigation of 160 cases including 30 autopsies from The Johns Hopkins Hospital and Massachusetts General Hospital. Medicine (Baltimore) 1952 Feb;31(1):1–132. [PubMed] [Google Scholar]
  14. Lebacq E., Desmet V., Verhaegen H. Renal involvement in sarcoidosis. Postgrad Med J. 1970 Aug;46(538):526–529. doi: 10.1136/pgmj.46.538.526. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Ljunghall S., Hedstrand H. Epidemiology of renal stones in a middle-aged male population. Acta Med Scand. 1975 Jun;197(6):439–445. doi: 10.1111/j.0954-6820.1975.tb04948.x. [DOI] [PubMed] [Google Scholar]
  16. MURPHY G. P., SCHIRMER H. K. Nephrocalcinosis, urolithiasis and renal insufficiency sarcoidosis. J Urol. 1961 Dec;86:702–706. doi: 10.1016/S0022-5347(17)65251-0. [DOI] [PubMed] [Google Scholar]
  17. Meria P., Anidjar M., Hermieu J. F., Boccon-Gibod L. Lithiase urinaire et grossesse. Prog Urol. 1993 Dec;3(6):937–943. [PubMed] [Google Scholar]
  18. Muther R. S., McCarron D. A., Bennett W. M. Renal manifestations of sarcoidosis. Arch Intern Med. 1981 Apr;141(5):643–645. [PubMed] [Google Scholar]
  19. Papapoulos S. E., Clemens T. L., Fraher L. J., Lewin I. G., Sandler L. M., O'Riordan J. L. 1, 25-dihydroxycholecalciferol in the pathogenesis of the hypercalcaemia of sarcoidosis. Lancet. 1979 Mar 24;1(8117):627–630. doi: 10.1016/s0140-6736(79)91076-6. [DOI] [PubMed] [Google Scholar]
  20. Papapoulos S. E., Clemens T. L., Fraher L. J., Lewin I. G., Sandler L. M., O'Riordan J. L. 1, 25-dihydroxycholecalciferol in the pathogenesis of the hypercalcaemia of sarcoidosis. Lancet. 1979 Mar 24;1(8117):627–630. doi: 10.1016/s0140-6736(79)91076-6. [DOI] [PubMed] [Google Scholar]
  21. Rømer F. K. Renal manifestations and abnormal calcium metabolism in sarcoidosis. Q J Med. 1980;49(195):233–247. [PubMed] [Google Scholar]
  22. Scott R. Prevalence of calcified upper urinary tract stone disease in a random population survey. Report of a combined study of general practitioners and hospital staff. Br J Urol. 1987 Feb;59(2):111–117. doi: 10.1111/j.1464-410x.1987.tb04799.x. [DOI] [PubMed] [Google Scholar]
  23. Selroos O. Bronchoalveolar lavage and biochemical markers in serum for monitoring disease activity and prognosis of sarcoidosis. Sarcoidosis. 1992 Sep;9(2):145–146. [PubMed] [Google Scholar]
  24. TAYLOR R. L., LYNCH H. J., Jr, WYSOR W. G., Jr Seasonal influence of sunlight on the hypercalcemia of sarcoidosis. Am J Med. 1963 Feb;34:221–227. doi: 10.1016/0002-9343(63)90055-x. [DOI] [PubMed] [Google Scholar]
  25. Yoshida O., Okada Y. Epidemiology of urolithiasis in Japan: a chronological and geographical study. Urol Int. 1990;45(2):104–111. doi: 10.1159/000281680. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES